Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians
Conclusion
These results highlight that CYP2C19*2, along with diabetes, and use of proton pump inhibitor and statin are important factors jointly associated with variability in clinical response to DAPT following ACS in Egyptians.
Source: Pharmacogenetics and Genomics - Category: Genetics & Stem Cells Tags: Original Articles Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Cholesterol | Clopidogrel | Diabetes | Egypt Health | Endocrinology | Genetics | Heart | Ischemic Stroke | Plavix | Proton Pump Inhibitors PPIs | Statin Therapy | Stroke | Study